Host: |
Mouse |
Applications: |
ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-HbA1c is suitable for use in ELISA research applications. |
Clonality: |
Monoclonal |
Clone ID: |
2403 |
Conjugation: |
Unconjugated |
Isotype: |
IgG1 |
Formulation: |
50 mM Na-citrate, pH 6.0, 0.9 % NaCI, 0.095 % NaN3 as a preservative |
Purification: |
Purity accurate to greater than or equal to 95% |
Concentration: |
5.0 mg/ml (+/-10 %) |
Storage Instruction: |
18 months from manufacturing at 2°C. Temperature analysis:-70 °C, 21 days N/D-20 °C, 21 days OK +4 °C, 21 days OK +30 °C, 21 OK +35 °C, 21 days OK +45 °C, 7 days OK. Shelf life stability testing at 2–8 °C in the product buffer. |
Association Rate Constant: |
8.9 x 105 1/Ms |
Determination Method: |
SPR analysis (ProteOn XPR36) |
Immunoreactivity: |
80–120 % compared to the reference sample in an FIA test |
Immunogen: |
human glycated hemoglobin A1 |
Background | Glycated hemoglobin (HbA1c) is formed in a non-enzymatic process during exposure to plasma glucose. Normal levels of glucose produce a normal amount of glycated hemoglobin. As the average amount of plasma glucose increases, the fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels over the previous months prior to the measurement. The 2010 American Diabetes Association Standards of Medical Care in Diabetes added the HbA1c ≥ 48 mmol/mol (≥ 6.5 %) as another criterion for the diagnosis of diabetes. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance